Keywords: isis, alicaforsen, fails, crohn, disease, trials, pharmaceuticals

Isis' alicaforsen fails in Crohn's disease trials

Article | 13 December 2004

Print This

Isis Pharmaceuticals of the USA says that two Phase III trials evaluating its first-generation antisense drug alicaforsen as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in